Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	938	952	1,515	1,433	1,222	-
Market Cap Growth	-27.00%	-37.19%	5.76%	17.23%	-	-
Enterprise Value	1,102	1,097	1,614	1,753	1,450	-
Last Close Price	31.28	31.72	49.14	45.57	38.87	-
PE Ratio	33.00	33.46	57.90	35.76	69.56	-
Forward PE	-	31.28	31.28	27.29	-	-
PS Ratio	1.07	1.09	1.73	1.84	1.71	-
PB Ratio	1.87	1.90	3.00	2.83	2.61	-
P/TBV Ratio	1.85	1.88	2.97	2.82	2.62	-
P/FCF Ratio	562.89	570.81	5.39	-	9.16	-
P/OCF Ratio	107.31	108.82	5.30	-	8.33	-
PEG Ratio	-	3.13	3.13	3.13	-	-
EV/Sales Ratio	1.26	1.25	1.84	2.26	2.03	-
EV/EBITDA Ratio	20.36	23.80	24.74	20.42	30.38	-
EV/EBIT Ratio	30.27	30.14	29.44	23.52	40.08	-
EV/FCF Ratio	660.77	657.92	5.74	-	10.86	-
Debt / Equity Ratio	0.38	0.38	0.41	0.72	0.44	0.56
Debt / EBITDA Ratio	3.54	3.54	2.79	3.80	3.82	2.79
Debt / FCF Ratio	114.87	114.87	0.74	-	1.55	-
Net Debt / Equity Ratio	0.34	0.34	0.24	0.68	0.32	0.47
Net Debt / EBITDA Ratio	3.71	3.71	1.84	4.03	3.19	2.42
Net Debt / FCF Ratio	102.59	102.59	0.43	-2.22	1.14	-2.78
Asset Turnover	0.93	0.93	0.85	0.76	0.73	0.73
Inventory Turnover	8.93	8.93	7.15	6.39	5.75	5.96
Quick Ratio	2.10	2.10	1.95	1.64	1.78	1.61
Current Ratio	2.44	2.44	2.41	1.97	2.21	1.99
Return on Equity (ROE)	5.21%	5.21%	6.17%	9.64%	3.31%	16.99%
Return on Assets (ROA)	2.41%	2.41%	3.33%	4.58%	2.32%	5.40%
Return on Invested Capital (ROIC)	3.58%	3.66%	5.05%	7.66%	3.10%	12.15%
Return on Capital Employed (ROCE)	6.20%	6.20%	9.30%	12.50%	6.50%	15.20%
Earnings Yield	3.03%	2.99%	1.73%	2.80%	1.44%	-
FCF Yield	0.18%	0.18%	18.57%	-10.86%	10.92%	-
Dividend Yield	3.24%	-	2.04%	2.19%	-	-
Payout Ratio	105.49%	105.49%	114.64%	-	113.85%	38.70%
Total Shareholder Return	3.23%	-	2.04%	2.19%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.